1-10 of 10
Elaine M. Majerus
Close
Sort by
Journal Articles

Real-World Treatment Outcomes of Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated with Pegcetacoplan and Complement Protein 5 Inhibitors (C5i)

Elaine M Majerus, Brian Mulherin, Koo Wilson, Jesse Fishman, Jennifer Mellor, Lucy Earl, Alexander Roeth
Journal: Blood
Blood (2023) 142 (Supplement 1): 5633.
https://doi.org/10.1182/blood-2023-181921
Published: 2023
Journal Articles

NKTT120 Safely Depletes iNKT Cells in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Joshua J. Field, MD MS, Elaine M. Majerus, MD PhD, Ken I. Ataga, MD, Elliott P. Vichinsky, MD, Cheryl Eaton, Rosemary Mazanet, MD PhD, David G. Nathan, MD
Journal: Blood
Blood (2015) 126 (23): 2178.
https://doi.org/10.1182/blood.V126.23.2178.2178
Published: 2015
Journal Articles

Von Willebrand Factor for Menorrhagia: A Survey and Literature Review

Nicoletta Machin, MD, Margaret V. Ragni, MD MPH, Lynn M. Malec, MD, Donald Brambilla, PhD, Thomas Coyle, MD, Joanna A. Davis, MD, Annette Drygalski, Andra H James, MD MPH, Shawn M Jobe, MD PhD, Barbara A. Konkle, MD, Peter Kouides, MD, Philip Kuriakose, MD, Alice D. Ma, MD, Elaine M. Majerus, MD PhD, Danielle Nance, MD, Anne T. Neff, MD, Claire S. Philipp, MD, Tzu-Fei Wang, MD, Hassan M. Yaish, MD
Journal: Blood
Blood (2015) 126 (23): 4694.
https://doi.org/10.1182/blood.V126.23.4694.4694
Published: 2015
Journal Articles

NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Elaine M. Majerus, MD PhD, Kenneth I. Ataga, MD, Elliott Vichinsky, MD, Cheryl A. Eaton, BA, Rosemary Mazanet, MD PhD, David G. Nathan, MD, Joshua J. Field, MD MS
Journal: Blood
Blood (2014) 124 (21): 2718.
https://doi.org/10.1182/blood.V124.21.2718.2718
Published: 2014
Journal Articles

After the treated mole

Armin Rashidi, Elaine M. Majerus
Journal: Blood
Blood (2014) 123 (18): 2757.
https://doi.org/10.1182/blood-2014-01-552406
Published: 2014
Journal Articles

Interaction of ADAMTS13 with the Endothelial Cell Surface.

Anthony Vomund, PhD, Elaine M. Majerus, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3710.
https://doi.org/10.1182/blood.V110.11.3710.3710
Published: 2007
Journal Articles

A Small Fragment of ADAMTS13 Enhances Cleavage of von Willebrand Factor by the Intact Enzyme.

Elaine M. Majerus, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1742.
https://doi.org/10.1182/blood.V110.11.1742.1742
Published: 2007
Journal Articles

A C-Terminal Exosite of von Willebrand Factor Domain A2 Interacts with ADAMTS13 Spacer Domain To Accelerate Substrate Cleavage.

Weiqiang Gao, MD, PhD, Patricia J. Anderson, PhD, Elaine M. Majerus, MD, PhD, Elodee A. Tuley, J. Evan Sadler, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 1785.
https://doi.org/10.1182/blood.V108.11.1785.1785
Published: 2006
Journal Articles

The C-Terminal α-Helix of von Willebrand Factor Domain A2 Interacts with ADAMTS13 C-Terminal Domains To Regulate Substrate Cleavage.

Weiqiang Gao, MD, PhD, Patricia J. Anderson, Ph.D, Elaine M. Majerus, MD, Ph.D, Elodee A. Tuley, J. Evan Sadler, MD,Ph.D
Journal: Blood
Blood (2005) 106 (11): 410.
https://doi.org/10.1182/blood.V106.11.410.410
Published: 2005
Journal Articles

Characterization of the Binding Interaction between ADAMTS13 and von Willebrand Factor (VWF).

Elaine M. Majerus, MD, PhD, Patricia J. Anderson, PhD, J. Evan Sadler, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 515.
https://doi.org/10.1182/blood.V104.11.515.515
Published: 2004